Get Fit Bharat

Tag: Static

HomeStatic

Former India coach Greg Chappell says Yashasvi Jaiswal appears to be in a good position to carry on the wonderful heritage of batting excellence created by Sachin Tendulkar and Virat Kohli. The Australian batting legend lauded Jaiswal's fearless approach and technical brilliance, which were on full display during his scintillating 161-run knock against Australia in …

In today's fast-paced society, where lifestyle-related diseases are on the rise, obesity has emerged as a serious health problem. Obesity is more than simply a cosmetic or physical issue; it is a medical problem that can have a substantial influence on one's entire health. Obese people are more likely to develop a variety of …

  Delhi, India:  Delhi Transport Stack, in collaboration with Japan International Cooperation Agency (JICA) and Foundation for Innovation and Technology Transfer (FITT) - IIT Delhi has launched the ‘Transport Stack Open Innovation Challenge’. Supported by MeitY Startup Hub, the challenge aims to facilitate data-driven transformative solutions, with Boston Consulting Group (BCG) acting as …

Akums Drugs & Pharmaceuticals Ltd., India's Largest contract development and manufacturing organization (CDMO), has announced a partnership with Jagdale Industries Private Ltd. (JIL), a pioneering name in India’s healthcare sector. This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in carton packing for the ready-to-drink (RTD) market, targeting an expansive array of health …

Mumbai, Maharashtra, India:  Sealmatic India Ltd, listed on the Bombay Stock Exchange (BSE: BOM: 543782) is pleased to announce the inauguration of its new state-of-the-art manufacturing facility at Kaman–Vasai, a significant leap towards enhancing its production capabilities. This new facility, spanning an impressive 25,000 sq ft, signifies a remarkable expansion, thus, …

Curasight recently released its Q3 report, reflecting on a period of good momentum. Publishing complete phase II results with uTRACE in brain cancer, the company announced that the indication will be the target for a first-in-human trial with uTREAT. Following the oversubscribed rights issue in September, further funding for the study …